{
    "clinical_study": {
        "@rank": "88898", 
        "arm_group": [
            {
                "arm_group_label": "Carbetocin", 
                "arm_group_type": "Experimental", 
                "description": "Carbetocin 100 \u00b5g, given as an intravenous bolus over 30 seconds others names are: duratocin, pabal"
            }, 
            {
                "arm_group_label": "Oxytocin", 
                "arm_group_type": "Active Comparator", 
                "description": "Other names are Pitocin, syntocinon given as an intravenous bolus over 30 seconds by the anaesthetist following clamping of the umbilical cord only in patient that has been randomized to this group."
            }
        ], 
        "brief_summary": {
            "textblock": "A double-blinded randomised control trial conducted in the Department of Obstetrics and\n      Gynaecology of a tertiary hospital, Universiti Kebangsaan Malaysia Medical Centre (UKMMC)\n      for two years duration from January 1st, 2012 till December 31st, 2013.\n\n      The aim of the study is to compare the haemodynamic and cardiovascular effects between\n      intravenous carbetocin 100 \u03bcg and intravenous oxytocin 5 IU in women undergoing elective\n      Lower Segment Caesarean Section (EL LSCS).\n\n      Study hypothesis: A single injection of carbetocin is haemodynamically and cardiovascularly\n      safe and has similar efficacy in comparison to a single injection of oxytocin."
        }, 
        "brief_title": "Haemodynamic and Cardiovascular Effects of Carbetocin and Oxytocin", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pregnancy Related", 
            "Anaesthesia"
        ], 
        "detailed_description": {
            "textblock": "OUTCOME MEASURES The drop of systolic blood pressure (SBP), diastolic blood pressure (DBP),\n      Heart Rate (HR), saturation of oxygen (SpO2) in certain time after drug injection.\n\n      The presence of myocardial ischemia symptoms and side effects of both drugs, ECG changes\n      such as ST depression and changes in T-waves.\n\n      The drop of hemoglobin and troponin-T level\n\n      The need for additional oxytocin infusion and estimated blood loss\n\n      The time interval between initial drug administration, type of additional oxytocic\n      intervention that used and complication that happened."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Viable, singleton pregnancy \u2265 37 weeks gestation undergoing EL LSCS.\n\n          2. Low risk for post-partum hemorrhage, such as no proven abruptio placentae, placenta\n             previa, multiple pregnancy, pre-eclampsia / gestational hypertension, previous PPH,\n             obesity (based on BMI pre pregnancy which is \u2265 30 kg/m2), big baby.\n\n          3. Ability to provide informed consent.\n\n        Exclusion Criteria:\n\n          1. Emergency caesarean section\n\n          2. Preterm Labour\n\n          3. Grandmultipara\n\n          4. Multiple Pregnancy\n\n          5. Placenta Previa\n\n          6. Previous PPH\n\n          7. Maternal Obesity ( BMI pre pregnancy \u2265 30 kg/m2))\n\n          8. Have co-morbidity illness such as hypertension/pre-eclampsia, established cardiac\n             diseases, history or evidence of liver, renal, vascular, or endocrine disease and\n             bleeding disorder.\n\n          9. Contraindication to carbetocin and oxytocin\n\n         10. Language Barrier\n\n         11. Women undergoing general anaesthesia\n\n         12. Women who has abnormal baseline ECG that suggestive myocardial ischemia"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01719952", 
            "org_study_id": "UKMMC"
        }, 
        "intervention": [
            {
                "arm_group_label": "Carbetocin", 
                "description": "IV carbetocin 100mcg, only in selected patient given as an intravenous bolus over 30 seconds by the anaesthetist following clamping of the umbilical cord only in patient that has been randomized to this group.\npitocin 5 IU also given as an intravenous bolus over 30 seconds by the anaesthetist following clamping of the umbilical cord only in patient that has been randomized to this group.", 
                "intervention_name": "Carbetocin", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Duratocin for carbetocin", 
                    "pitocin for oxytocin"
                ]
            }, 
            {
                "arm_group_label": "Oxytocin", 
                "description": "5 IU given as an intravenous bolus over 30 seconds by the anaesthetist following clamping of the umbilical cord only in patient that has been randomized to this group.", 
                "intervention_name": "Oxytocin", 
                "intervention_type": "Drug", 
                "other_name": "pitocin"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Oxytocin", 
                "Carbetocin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pregnancy", 
            "anaesthesia", 
            "caesarean section"
        ], 
        "lastchanged_date": "June 6, 2013", 
        "location": {
            "contact": {
                "email": "nirmala_k@hotmail.com", 
                "last_name": "Nirmala C Kampan, MRCOG(UK)", 
                "phone": "60391455950", 
                "phone_ext": "5949"
            }, 
            "facility": {
                "address": {
                    "city": "Cheras", 
                    "country": "Malaysia", 
                    "state": "Kuala Lumpur", 
                    "zip": "56000"
                }, 
                "name": "Department of O&G"
            }, 
            "investigator": {
                "last_name": "Nirmala C Kampan, MRCOG(UK)", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Malaysia"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Haemodynamic and Cardiovascular Effects of Carbetocin and Oxytocin in Women Undergoing Elective Caesarean Section: A Double-blinded Randomised Clinical Trial", 
        "overall_official": {
            "affiliation": "Universiti Kebangsaan Malaysia Medical Centre", 
            "last_name": "Nirmala C Kampan, MRCOG(UK)", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Malaysia: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Haemodynamic effect (blood pressure, heart rate, saturation of oxygen)\nPresence of ECG changes such as ST depression and changes in T-waves\nPresence of myocardial ischemia symptoms (such as chest pain, shortness of breath, feeling of heaviness in chest pain)\nTo compare the troponin T levels", 
            "measure": "Haemodynamic effects", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01719952"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universiti Kebangsaan Malaysia Medical Centre", 
            "investigator_full_name": "Nirmala Chandralega Kampan", 
            "investigator_title": "MRCOG(UK)", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Need for additional oxytocin infusion\nTotal blood loss\nDrop in haemoglobin level post-operatively", 
            "measure": "Blood loss measurement", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "Universiti Kebangsaan Malaysia Medical Centre", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universiti Kebangsaan Malaysia Medical Centre", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}